On May 2, 2023, Nicole Steinmetz, Ph.D., advised the board of directors of Mosaic ImmunoEngineering, Inc. of her intention to resign as a member of the board of directors and acting Chief Scientific Officer effective immediately. Dr. Steinmetz confirmed to the Company's board of directors that her resignation is not due to a disagreement with the Company on any matter relating to the Company's operations, policies or practices. Dr. Steinmetz will remain engaged with the Company as a scientific advisor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.39 USD | -2.50% | +2.63% | -35.00% |
1st Jan change | Capi. | |
---|---|---|
-35.00% | 2.9M | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |
- Stock Market
- Equities
- CPMV Stock
- News Mosaic ImmunoEngineering, Inc.
- Mosaic Immunoengineering, Inc. Announces Nicole Steinmetz, Ph.D., to Resign as A Member of the Board of Directors and Acting Chief Scientific Officer